Blanket Purchase Agreement 36F79724D0080-36E79724A0025
Award Date
8/1/24
Last Date to Order
7/31/25
Federal Agency
National Acquisition Center
Awardee
Adma Biologics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
Adma Biologics, Inc., a for-profit pharmaceutical company, was awarded a Federal Supply Schedule (FSS) contract by the Department of Veterans Affairs' Veterans Integrated Service Network 12 (VISN 12). The contract, valued up to $1,549,720, is for the provision of drugs, pharmaceuticals, and hematology-related products, with a period of performance through July 14, 2029. Additionally, Adma Biologics was awarded a $49,000,000 Blanket Purchase Agreement (BPA) by the National Acquisition Center, a...
The Federal Supply Schedule (FSS) contract #36F79724D017E, awarded to Adma Biologics, Inc., provides the Department of Veterans Affairs (VA) and its Veterans Integrated Service Network 12 (VISN 12) with access to a variety of pharmaceutical and hematology-related products. The contract has a ceiling value of $25,000 and runs through July 14, 2024. Adma Biologics, a for-profit organization, specializes in plasma-derived therapeutics, with specific products referenced including ASCENIV and...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to CSL Behring L.L.C., a global biotherapeutics company that provides specialty pharmaceutical products to the VA. The BPA has a ceiling value of $17,500,000 and allows VA facilities nationwide to efficiently order the medication HAEGARDA, a C1 inhibitor treatment for hereditary angioedema, as needed through September 2025. The VA Greater Los Angeles Healthcare System...
This Blanket Purchase Agreement (BPA) was awarded by the Office of Logistics and Acquisition Operations, a civilian federal agency, to Southern Biotechnology Associates Inc. as a single award contract with a ceiling value of $100,000,000 and a period of performance through August 31, 2025. The BPA is intended to procure operation and maintenance items including chemicals, blood/blood products, biological materials and media, and animal services. The broad scope of the contract suggests it may...
The Blanket Purchase Agreement (BPA) is a federal contract indefinite delivery vehicle (IDV) awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Genzyme Corporation, doing business as Sanofi Genzyme. The BPA has a ceiling value of $3,000,000 and a period of performance from June 6, 2024 to June 5, 2026. The purpose of the BPA is to provide the VA with a streamlined contracting method to procure specialty pharmaceutical products,...
This Blanket Purchase Agreement (BPA) is a federal contract Indefinite Delivery Vehicle (IDV) awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to the prime contractor Lofstrand Labs LTD. The contract has a ceiling value of $10,000,000.00 and a period of performance through July 31, 2025. The BPA is for the procurement of biological materials and blood/blood products for operations and maintenance. No set-asides were used. The contract aims to provide the agency...
This Blanket Purchase Agreement (BPA) was awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Southern Biotechnology Associates Inc. The BPA has a ceiling value of $1,000,000.00 and a period of performance through August 31, 2024. The BPA is intended to procure biological materials, blood/blood products, chemicals, and media. The prime contractor, Southern Biotechnology Associates Inc., is a for-profit manufacturer of goods organized as a Subchapter S...
The National Acquisition Center, a civilian agency of the Department of Veterans Affairs (VA), has awarded a single-award Blanket Purchase Agreement (BPA) to Bio Products Laboratory LIMITED, a for-profit manufacturer of pharmaceutical goods. The BPA, valued at up to $1,125,000 over a base year with four one-year option periods through April 2026, is for the procurement of ALBUMINEX albumin products to be delivered to VA medical facilities nationwide. This BPA is established under the VA's...
The Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Bio Products Laboratory LIMITED for the procurement of albumin products. The single award BPA has a potential value of $37,811.50 for a base year with four option years and aims to procure albumin products through March 31, 2022 under Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. The BPA was awarded on April 24, 2021 without a set-aside designation to Bio Products...
The provided Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to United Drug Supply Inc., a woman-owned small business. The single-award, indefinite delivery contract has a ceiling value of $20,700,000 and a period of performance through September 14, 2026. The contract vehicle was established under the General Services Administration Federal Supply Schedule (FSS) 65-II-A for...